Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
Fibroblast Growth Factor 21 Variants
Abstract: This present invention relates to pharmacologically potent and/or stable variants of human fibroblast growth factor 21 (FGF21) pharmaceutical compositions comprising FGF21 variants and methods for treating type 2 diabetes obesity dyslipidemia or metabolic syndrome or any combination thereof using such variants.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
30 January 2014
Publication Number
14/2015
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285
Inventors
1. DICKINSON Craig Duane
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis IN 46206 6288
2. DRIVER David Albert
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis IN 46206 6288
3. DARLING Ryan James
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis IN 46206 6288
4. GONCIARZ Malgorzata Donata
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis IN 46206 6288
5. MICANOVIC Radmila
c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis IN 46206 6288